Axogen To Acquire NerveTape Maker BioCircuit Technologies For $200M In Cash; Sees Deal As Accretive To FY27 Gross And Adjusted EBITDA Margins

Loading news article.

Axogen To Acquire NerveTape Maker BioCircuit Technologies For $200M In Cash; Sees Deal As Accretive To FY27 Gross And Adjusted EBITDA Margins | WAPE

Article summary